Arlington Partners’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,500
Closed -$7.37K 175
2023
Q4
$7.37K Hold
1,500
﹤0.01% 233
2023
Q3
$8.18K Hold
1,500
﹤0.01% 242
2023
Q2
$13.9K Hold
1,500
﹤0.01% 433
2023
Q1
$12.3K Hold
1,500
﹤0.01% 401
2022
Q4
$16.7K Hold
1,500
﹤0.01% 323
2022
Q3
$18K Sell
1,500
-3,965
-73% -$60.1K 0.01% 270
2022
Q2
$83K Sell
5,465
-6,263
-53% -$113K 0.03% 187
2022
Q1
$248K Hold
11,728
0.07% 102
2021
Q4
$277K Hold
11,728
0.07% 96
2021
Q3
$235K Buy
11,728
+3,965
+51% +$81.3K 0.07% 96
2021
Q2
$156K Hold
7,763
0.05% 99
2021
Q1
$165K Hold
7,763
0.06% 103
2020
Q4
$169K Hold
7,763
0.08% 68
2020
Q3
$137K Hold
7,763
0.08% 70
2020
Q2
$146K Hold
7,763
0.08% 72
2020
Q1
$134K Buy
7,763
+6,263
+418% +$131K 0.07% 88
2019
Q4
$32K Buy
+1,500
New +$30.4K 0.02% 150

Other funds holding MPT

Arlington Partners's MPT Position: Q1 2024 in Review

Arlington Partners sold out of Medical Properties Trust (MPT) in Q1 2024, closing a stake of 1,500 shares — an estimated $7.37K sold.

Arlington Partners first reported a position in MPT in Q4 2019 and held it in 17 quarters. The position peaked at $277K in Q4 2021. 510 funds tracked by Wall St. Rank hold MPT as of Q1 2024.

  • Arlington Partners reported no remaining Medical Properties Trust position as of Q1 2024 after selling out during the quarter.
  • Arlington Partners sold 1,500 Medical Properties Trust shares in Q1 2024, an estimated $7.37K.
  • Arlington Partners first reported a position in Medical Properties Trust in Q4 2019 and held it in 17 quarters.
  • Arlington Partners's Medical Properties Trust position peaked at $277K in Q4 2021.
  • 510 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2024.

Based on Arlington Partners's 13F filing for Q1 2024, filed 16 Apr 2024.